Crystalline Deposition in a Nose With a Sinus Tract
J Rheumatol. 2025 Aug 15:jrheum.2025-0439. doi: 10.3899/jrheum.2025-0439. Online ahead of print. NO ABSTRACT PMID:40816740 | DOI:10.3899/jrheum.2025-0439
J Rheumatol. 2025 Aug 15:jrheum.2025-0439. doi: 10.3899/jrheum.2025-0439. Online ahead of print. NO ABSTRACT PMID:40816740 | DOI:10.3899/jrheum.2025-0439
J Rheumatol. 2025 Aug 15:jrheum.2025-0405. doi: 10.3899/jrheum.2025-0405. Online ahead of print. ABSTRACT OBJECTIVE: Psoriatic Disease (PsD) is a chronic, multisystem
J Rheumatol. 2025 Aug 15:jrheum.2025-0476. doi: 10.3899/jrheum.2025-0476. Online ahead of print. ABSTRACT There are several potential factors that predict the
J Rheumatol. 2025 Aug 15:jrheum.2025-0531. doi: 10.3899/jrheum.2025-0531. Online ahead of print. ABSTRACT The interplay between metabolic health and autoimmune diseases
J Rheumatol. 2025 Aug 15:jrheum.2025-0097. doi: 10.3899/jrheum.2025-0097. Online ahead of print. ABSTRACT OBJECTIVE: Investigate use and timing of rehabilitation services
J Rheumatol. 2025 Aug 15:jrheum.2025-0514. doi: 10.3899/jrheum.2025-0514. Online ahead of print. NO ABSTRACT PMID:40816734 | DOI:10.3899/jrheum.2025-0514
J Rheumatol. 2025 Aug 15:jrheum.2025-0751. doi: 10.3899/jrheum.2025-0751. Online ahead of print. NO ABSTRACT PMID:40816733 | DOI:10.3899/jrheum.2025-0751
J Rheumatol. 2025 Aug 15:jrheum.2025-0263. doi: 10.3899/jrheum.2025-0263. Online ahead of print. ABSTRACT The Young Group for Research and Assessment of
Biologic Switching in Psoriasis A systematic review and meta-analysis found that biologic switching was effective in a https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri,
… Rheumatology · Surgery · AI EvidencePulseâ„¢ · Pharma · The Scan+ · Classicsâ„¢+ · 2MM+ … Rheumatology. Reading Time:
This was in what I call the Dark Ages of rheumatology, before effective treatment—or indeed, any treatment at all; I
JMIR Res Protoc. 2025 Aug 15;14:e74999. doi: 10.2196/74999. ABSTRACT BACKGROUND: Psoriasis is a chronic inflammatory disease associated with multiple comorbidities,
Mod Rheumatol. 2025 Aug 15:roaf076. doi: 10.1093/mr/roaf076. Online ahead of print. ABSTRACT OBJECTIVE: Myocardial involvement in idiopathic inflammatory myopathy (IIM)
J Clin Rheumatol. 2025 Aug 15. doi: 10.1097/RHU.0000000000002275. Online ahead of print. ABSTRACT BACKGROUND/OBJECTIVE: The DANGER (Death in ANCA Glomerulonephritis-Estimating
J Clin Rheumatol. 2025 Aug 15. doi: 10.1097/RHU.0000000000002271. Online ahead of print. NO ABSTRACT PMID:40815808 | DOI:10.1097/RHU.0000000000002271
J Clin Rheumatol. 2025 Aug 15. doi: 10.1097/RHU.0000000000002270. Online ahead of print. ABSTRACT BACKGROUND: To compare the clinical features and
Sci Immunol. 2025 Aug 15;10(110):eadt3955. doi: 10.1126/sciimmunol.adt3955. Epub 2025 Aug 15. ABSTRACT Peripheral helper T (TPH) cells can play pathogenic
There’s a transient (1 yr) increase in New Abx Rx among 399 PsA pts after starting a TNF inhibitor. Pre-TNFi,
healio rheumatology logo. Sources/Disclosures. Collapse. Source: Press Release. Read more about. fibromyalgia · oral aphthous ulcer · fda. Add topic …
Editor’s note: This is a developing news story. Please check back soon for updates.The FDA approved Tonmya, a first-in-class, non-opioid,
Pain Flares in RA are just pain, not inflammation. Study of 195 RA pts (11+ yrs dz dur), 49-89% experienced
Front. Med. Sec. Rheumatology. Volume 12 – 2025 | doi: 10.3389/fmed.2025.1655165Â …
Difficult to manage SpA (D2M-axSpA) defined as failure ≥ 2 b/tsDMARDs (diff MOAs). Study of 129 axSpA pts, 8.5% were https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
… Sjogren’s the same again. Connected Rheumatology•41K views · 13:39 · Go to channel. How to Spot Autism in High-Masking
Rising health care costs and federal policy changes are driving up premium rates for the growing number of Americans covered
Wisdom of Medical Aphorisms The American Journal of Medicine and Dr. Joseph S. Alpert have curated insightful aphorism https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
At the time of the FOI examination, 26 (48.1%) of PsA patients were treated with disease-modifying anti-rheumatic drugs (DMARDs); of